Non-operative advances: what has happened in the last 50 years in paediatric surgery?

Andrew J A Holland1, Craig A McBride

  • 1The Children's Hospital at Westmead Burns Research Institute, Burns Unit and Douglas Cohen Department of Paediatric Surgery, The University of Sydney, Sydney, New South Wales, Australia.

Insights

Paediatric surgeons leverage advancements beyond the operating room, including specialized care units and innovative dressings, to improve surgical outcomes for children. These innovations enhance survival rates and recovery for infants with congenital anomalies and children with burns.

Area of Science:

  • Pediatric Surgery
  • Surgical Innovation
  • Congenital Anomaly Treatment

Background:

  • Paediatric surgeons are essential clinicians for children requiring operative intervention.
  • Advances in paediatric surgical care extend beyond the operating theatre, involving multidisciplinary teams.
  • Neonatal intensive care units significantly improve survival and outcomes for infants with congenital anomalies.

Observation:

  • Educational initiatives like advanced trauma life support enhance clinical care.
  • Paediatric surgeons lead non-operative management of blunt abdominal trauma.
  • Novel nano-crystalline burn wound dressings reduce dressing changes and improve healing.

Findings:

  • Specialized neonatal intensive care units enhance survival rates for infants with major congenital anomalies.
  • Advanced trauma and burn management courses improve clinical understanding and care.
  • Nano-crystalline dressings offer antimicrobial efficacy and promote burn wound healing.
  • Burns care now frequently utilizes ambulatory or day-case settings with predictive technologies.

Implications:

  • Multidisciplinary collaboration is key to advancing paediatric surgical care.
  • Technological innovations are transforming the management of paediatric surgical conditions.
  • Improved outcomes and reduced patient burden are achievable through modern paediatric surgical practices.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
886
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
371
Psychosurgery01:30

Psychosurgery

Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
2.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391